NUVL Q4 2025 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$102M

Net Income

-$119M

EPS (Diluted)

$-1.58

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$73M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$164M

Stockholders' Equity

$1.2B

Cash & Equivalents

$262M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$102M	-$86M	-18.5%
Net Income	-$119M	-$75M	-58.8%